Alnylam Pharmaceuticals, Inc.

Alberta Investment Management Corp ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/19/2026

Shares

12,600

Value ($000)

5,010

Weight

0.0%

2019 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/19/2026	5,010	0.0%	12,600	12/31/2025
2025 Q3	2/17/2026	5,335	0.0%	11,700	9/30/2025
2025 Q1	5/8/2025	4,779	0.0%	17,700	3/31/2025
2024 Q4	2/3/2025	4,236	0.0%	18,000	12/31/2024
2024 Q3	11/5/2024	1,898	0.0%	6,900	9/30/2024
2024 Q1	5/15/2024	433	0.0%	2,900	3/31/2024
2023 Q4	2/12/2024	1,373	0.0%	7,175	12/31/2023
2023 Q3	11/14/2023	514	0.0%	2,900	9/30/2023
2023 Q2	8/24/2023	551	0.0%	2,900	6/30/2023
2023 Q1	5/15/2023	581	0.0%	2,900	3/31/2023
2021 Q2	8/16/2021	14,375	0.1%	84,800	6/30/2021
2021 Q1	5/7/2021	12,538	0.1%	88,800	3/31/2021
2020 Q4	2/16/2021	12,256	0.1%	94,300	12/31/2020
2020 Q3	10/26/2020	11,794	0.1%	81,000	9/30/2020
2020 Q2	8/11/2020	10,442	0.1%	70,500	6/30/2020
2020 Q1	5/8/2020	5,660	0.1%	52,000	3/31/2020
2019 Q4	2/14/2020	5,989	0.1%	52,000	12/31/2019